KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Non-Current Debt (2018 - 2025)

Elanco Animal Health's Non-Current Debt history spans 8 years, with the latest figure at $3.9 billion for Q4 2025.

  • For Q4 2025, Non-Current Debt fell 7.81% year-over-year to $3.9 billion; the TTM value through Dec 2025 reached $3.9 billion, down 7.81%, while the annual FY2025 figure was $3.9 billion, 7.81% down from the prior year.
  • Non-Current Debt for Q4 2025 was $3.9 billion at Elanco Animal Health, roughly flat from $4.0 billion in the prior quarter.
  • Across five years, Non-Current Debt topped out at $6.3 billion in Q3 2021 and bottomed at $3.9 billion in Q4 2025.
  • The 5-year median for Non-Current Debt is $5.5 billion (2021), against an average of $5.3 billion.
  • The largest annual shift saw Non-Current Debt surged 172.95% in 2021 before it fell 26.52% in 2024.
  • A 5-year view of Non-Current Debt shows it stood at $6.0 billion in 2021, then fell by 9.58% to $5.4 billion in 2022, then grew by 5.29% to $5.7 billion in 2023, then fell by 25.44% to $4.3 billion in 2024, then fell by 7.81% to $3.9 billion in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Non-Current Debt are $3.9 billion (Q4 2025), $4.0 billion (Q3 2025), and $4.1 billion (Q2 2025).